Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

PRP more effective than minoxidil 5% for treating alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Non-immune factors play a significant role in alopecia areata.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

Certain gene variations increase the risk of alopecia areata in Koreans.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Higher RBP4 levels found in people with two types of hair loss.